x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Dr. Chapa’s OBGYN Clinical Pearls

Dr. Chapa’s Clinical Pearls

Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! Welcome...to Clinical Pearls.

science

All Episodes

00:16:03

Duration of PP MagSulfate: New Data

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/03/14

Why is Magnesium Sulfate the first-line medication for preeclampsia/eclampsia? How did that arise into the current, international, standard-of-care regiment for that condition? Is 24 hours of Postpartum Mag evidence-based? In this episode we will review the evolution of magnesium sulfate for eclampsia prevention/treatment. We will also summarize a soon to be released systematic review and meta-analysis publication from Obstetrics & Gynecology examining the duration of postpartum MagSulfate use

en

00:18:42

OB Care After ART (SMFM Series #60; 2022)

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/03/07

Pregnancies that arise after assisted reproductive technologies (ART) are at higher risk of maternal, fetal, and even placental complications. In this session we will summarize and highlight key prenatal management pearls for pregnancies that arise after ART. This is a summary of the SMFM consult series # 60, from March 2022.

en

00:16:03

Statins and Preeclampsia Prevention: Yes or No.

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/03/03

Preeclampsia occurs in 3 to 5% of the general OB population. It has even higher prevalence among those with high-risk conditions. Currently, aspirin stands alone as the most evidence-based pharmacological option for preeclampsia prevention (risk reduction). But over the last decade new interest has arisen for the use of statins for preeclampsia prevention. Well, do statins work? What is the state of statin therapy as of 2022? In this session we will review the latest data and review the key

en

00:18:13

Optimizing Natural Fertility (ASRM)

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/02/26

Couples trying to conceive often ask questions like these: When is the best time to have sex to get pregnant? Is there a better sexual position to have sex in order to conceive? Is one type of over the counter lubrication better than the other? Well despite weird myths and misperceptions about these subjects, there are firm answers we can give. In this podcast we will cover the January 2022 ASRM Bulletin on ways to “optimize natural fertility”.

en

00:12:50

Water Immersion in Labor: AAP/ACOG vs ACNM

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/02/22

Hydrotherapy (water immersion) has a proven safety record and proven benefits in the first stage of labor. But what about actually delivering with water immersion? In January 2022, the AAP released a Committee Opinion regarding water immersion delivery. The AAP echoes the words from the ACOG regarding water immersion births. However, the ACNM does not agree. In this session, we will review the established and conflicting viewpoints from these organizations regarding water immersion in labor and

en

00:16:06

23AndMe and OCPs

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/02/17

The old adage, “Too much of anything is a bad thing”, is traditionally credited to Mark Twain. Was he right? Does the same apply to medical information?What about finding incidental genetic carrier states from online companies like “23AndMe”? In a patient with no personal or family history of any medical complication or malignancy, is this information helpful or more psychologically harmful? In this episode we will review a recent real-world case of how gynecological care was impacted by a patient’s

en

00:20:30

Allergic to Semen!

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/02/08

Semen allergy is a real (although rare) immune reaction. Do you know what the presenting signs/symptoms are?The ISSM has established diagnostic criteria for this. In this session, we will review the diagnostic algorithm for a patient presenting with possible semen allergy.

en

00:14:57

Did WHO Ban Bakri?

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/02/05

Postpartum hemorrhage continues to be a worldwide leaning cause of maternal morbidity and mortality. In May 2021, the WHO updated it’s global recommendations for the use of “uterine balloon tamponade” in the management of PPH. Did the WHO ban the Bakri? In the session we will review the May 2021 WHO updated guidance and summarize a soon to be released guideline commentary from the ACOG (proposed release date March 2022).

en

00:12:35

Birth During Covid and Child Development: NEW DATA

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/01/20

Globally, more than 200 million infants have been born since the onset of the COVID-19 pandemic. It has been unclear whether fetal exposure to maternal SARS-CoV2 infection can adversely affect the child’s neurodevelopmental progress. Does having Covid during pregnancy affect the child’s neurodevelopment? The answer is intriguing! This is a tale of a pandemic, psychosocial stress response, and epigenetic changes. (Data summary from JAMA Pediatrics; Jan 2022).

en

00:05:25

NEW ACOG ADVISORY: JAN 2022

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/01/15

In the ACOG Practice Bulletin #106, which was released in 2009, the use of maternal supplemental oxygen for fetal heart rate tracing correction is mentioned. In that original bulletin, it states “despite inadequate data to support its use” consideration can be given to supplemental maternal oxygen for category II or III fetal heart rate tracings. However, within the last 7 years, an ever-growing body of evidence has proven that supplemental oxygen for fetal heart rate pattern abnormalities is not

en

00:19:14

OB HTN UPDATES (BIG CMQCC Recommendations).

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/01/13

Hypertensive disorders in pregnancy are a large contributor to maternal mortality. Maternal mortality rates for chronic hypertension in pregnancy have increased 15-fold over the last 4 decades! The California Maternal Quality Care Collaborative (CMQCC) has been a leading authority in the Pregnancy Hypertensive space. In the session, we will review BIG updates from the CMQCC. Should we aggressively treat chronic hypertension in pregnancy? What about treating nonsevere gestational hypertension? Are

en

00:11:23

New Data on Periods After Covid Vaccination

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/01/07

Concerns about a possible association between COVID-19 vaccination and abnormal menstrual cycles may lead to vaccine hesitancy. Social media sites have claimed that cycles are affected, although temporarily, after vaccination. Is this true? In the session, we will summarize a soon to be released publication out of Obstetrics and Gynecology which helps clarify this issue. We will also highlight a press release from January 6, 2022 from a major news outlet which seemingly appears to distort those

en

00:10:59

Repeat CS timing with 2+ CSs

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/01/06

Women with multiple prior low-transverse CSs show a trend toward increased risk of rupture compared with a single prior CS. While some have advocated planned repeat CS at 39 weeks as in patients with a SINGLE previous cesarean, planned repeat CD at 38 weeks is likely to be associated with a lower risk of uterine rupture. Yet, there is no consensus on best practice. In this session, we will summarize a new AJOG publication (Jan 2022) that raises some interesting and clinically meaningful data

en

00:12:18

Zmax Beats E-Mycin for PPROM Care

Dr. Chapa’s OBGYN Clinical Pearls ·

2022/01/04

In 1997, Mercer et al first published their data on antibiotic use for PPROM latency. With IV Erythromycin shortages, Zmax is a known substitute. New data (EPUB December 2021) now points to Zithromax’s validated clinical advantage over Erythromycin in this protocol. In this session, we will review this soon to be released publication in AJOG.

en

00:16:24

Not All LARCS Are Equal!

Dr. Chapa’s OBGYN Clinical Pearls ·

2021/12/29

Traditionally, physicians have informed patients that long acting reversible contraceptives are “just as effective“ as female sterilization. While as a Class that statement is correct, not all individual LARCS have the same efficacy; one in particular beats all other birth control methods, hands-down. Do you know which one? In this session we will review key facts regarding female sterilization and review the individual efficacies of long acting reversible contraceptives. We will also review the

en

00:09:46

Tale of 2 Anti-Covid ORAL MEDS: Ok for Pregnancy?

Dr. Chapa’s OBGYN Clinical Pearls ·

2021/12/23

As of December 23, 2021 the FDA has granted Emergency Use Authorization to 2 different oral medications (Pfizer; Merck) in the fight against Covid-19. Do you know the differences between PAXLOVID and molnupiravir (LAGEVRIO)? What are their indications for use? Are both allowable in pregnancy? This information is “hot off the press” and will update you on these 2 new, novel therapies.

en

00:07:57

Nonvigorous Newborn & Delayed Cord Clamping

Dr. Chapa’s OBGYN Clinical Pearls ·

2021/12/22

In our previous podcast, we stated that – due to lack of data – early cord clamping may be considered with nonvigorous neonates. However, the babies that may benefit the most (preterm or extremely pre-term) are often “nonvigorous” at birth. So how do we reconcile this issue? This podcast will answer this dilemma, summarizing points from the January 2022 CME publication on “Placental Transfusion of the Neonate“.

en

00:23:05

Placental Transfusion of the Neonate (Jan 2022 ACOG...

Dr. Chapa’s OBGYN Clinical Pearls ·

2021/12/19

There are 3 umbilical cord management strategies at time of delivery: (1) Early cord clamping, (2) Delayed clamping, and (3) Cord milking. How long should umbilical cord clamping be delayed? Is cord milking beneficial or potentially harmful? Are you familiar with the contraindications to delayed umbilical cord clamping? In this session, we will review this soon to be released CME article from Obstetrics & Gynecology (The Green Journal) covering “placental transfusion of the neonate”.

en

00:11:52

SSE: To Lube or Not to Lube.

Dr. Chapa’s OBGYN Clinical Pearls ·

2021/12/15

The clinical gold standard for the diagnosis of ruptured membranes is the sterile speculum examination (SSE). Tests like Amnisure or ROM+ are considered ancillary and supplemental. What is best clinical practice for performing a SSE? In the session we will review this procedure, discuss ancillary testing, and answer the age-old-question… “To lube or not to lube”.

en

00:09:29

Postpartum Foot Drop

Dr. Chapa’s OBGYN Clinical Pearls ·

2021/12/06

Postpartum neuropathies are an infrequent occurrence but can significantly impact a patient’s quality of life. Are you familiar with “strawberry picker’s” neuropathy? It is the most common type of nerve injury during vaginal delivery. In the session, we will review safe maternal positioning during vaginal delivery.

en

1,102 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter